Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity

Brain

Volumn 134, Issue 1, 2011, Pages 84-99

  Reitmeir, Raluca ^a   Kilic, Ertugrul ^b   Kilic, Ülkan ^b   Bacigaluppi, Marco ^c   Elali, Ayman ^a   Salani, Giuliana ^c   Pluchino, Stefano ^c   Gassmann, Max ^d   Hermann, Dirk M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b YEDITEPE UNIVERSITY   (Turkey)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

axonal growth; focal cerebral ischaemia; hematopoietic growth factor; inflammation

Indexed keywords

AMINE; DEXTRAN; GROWTH FACTOR; RECOMBINANT ERYTHROPOIETIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTOSIS; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN STEM; BRAIN TISSUE; CELL SURVIVAL; CONTROLLED STUDY; CONVALESCENCE; FACIAL NERVE NUCLEUS; FORELIMB; GENE EXPRESSION; GRIP STRENGTH; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR COORDINATION; MOTOR CORTEX; MOUSE; NERVE CELL PLASTICITY; NERVE FIBER; NERVE SPROUTING; NONHUMAN; PARESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SCAR FORMATION; STROKE;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN ISCHEMIA; ERYTHROPOIETIN; EXPLORATORY BEHAVIOR; HAND STRENGTH; IMMUNOHISTOCHEMISTRY; MALE; MICE; MOTOR ACTIVITY; NEURONAL PLASTICITY; NEURONS; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROTAROD PERFORMANCE TEST; STROKE;

EID: 78650699119     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq344     Document Type: Article

References (55)

1. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. Plos Med 2009; 6: e1000029.
2. Andrews EM, Tsai SY, Johnson SC, Farrer JR, Wagner JP, Kopen GC, et al. Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp Neurol 2008; 211: 588-92.
3. Bacigaluppi M, Pluchino S, Jametti LP, Kilic E, Kilic U, Salani G, et al.Delayed post-ischemic neuroprotection following systemic neural stemcell transplantation involves multiple mechanisms. Brain 2009; 132:2239-51.
4. Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, et al. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 2000; 30: 271-8.
5. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999; 19: 643-51.
6. Biernaskie J, Chernenko G, Corbett D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci 2004; 24: 1245-54.
7. Bonita R, Anderson CS, Broad JB, Jamrozik KD, Stewart-Wynne EG, Anderson NE. Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based stroke registers. Stroke 1994; 25: 552-7.
8. Brown CE, Li P, Boyd JD, Delaney KR, Murphy TH. Extensive turnover of dendritic spines and vascular remodeling in cortical tissues recovering from stroke. J Neurosci 2007; 27: 4101-9.
9. Buchli AD, Schwab ME. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med 2005; 37: 556-67.
10. Canals S, Beyerlein M, Keller AL, Murayama Y, Logothetis NK. Magnetic resonance imaging of cortical connectivity in vivo. Neuroimage 2008; 40: 458-72.
11. Carmichael ST, Li S. Growth-associated gene and protein expression in the region of axonal sprouting in the aged brain after stroke. Neurobiol Dis 2006; 23: 362-73.
12. Carmichael ST, Wei L, Rovainen CM, Woolsey TA. New patterns of intracortical projections after focal cortical stroke. Neurobiol Dis 2001; 8: 910-22.
13. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Zhang C, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003; 53: 743-51.
14. Cramer SC, Chopp M. Recovery recapitulates ontogeny. Trends Neurosci 2000; 23: 265-71.
15. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK, et al. A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 1997; 28: 2518-27.
16. Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Ledbetter KA, et al. Magnetic resonance imaging investigation of axonal remodeling and angiogen-esis after embolic stroke in sildenafil-treated rats. J Cereb Blood Flow Metab 2008; 28: 1440-8.
17. Dobkin BH. Neurologic rehabilitation. Philadelphia: FA Davis; 1996.
18. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8: 495-505.
19. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009; 40: e647-56.
20. Gerloff C, Bushara K, Sailer A, Wassermann EM, Chen R, Matsuoka T, et al. Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain 2006; 129: 791-808.
21. Grimm C, Hermann DM, Bogdanova A, Hotop S, Kilic U, Wenzel A, et al. Neuroprotection by hypoxic preconditioning: HIF-1 and erythro-poietin protect from retinal degeneration. Semin Cell Dev Biol 2005; 16: 531-8.
22. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-29.
23. Hermann DM, Zechariah A. Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. J Cereb Blood Flow Metab 2009; 29: 1620-43.
24. Hudson JQ, Sameri RM. Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease. Pharmacotherapy 2002; 22: 141S-9S.
25. Kilic E, ElAli A, Kilic U, Guo Z, Ugur M, Uslu U, et al. Role of Nogo-A inneuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab 2010; 30: 969-84.
26. Kilic E, Kilic Ü, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005a; 19: 2026-8.
27. Kilic Ü, Kilic E, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.FASEB J 2005b; 19: 249-51.
28. ̈ Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. Thephosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuropro-tective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 2006 20 1185-7.
29. Kilic E, Spudich A, Kilic U, Rentsch KM, Vig R, Matter CM, et al. ABCC1:a gateway for pharmacological compounds to the ischaemic brain.Brain 2008. 131, 2679-89.
30. King CE, Rodger J, Bartlett C, Esmaili T, Dunlop SA, Beazley LD. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transaction. Exp Neurol 2007; 205: 48-55.
31. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, et al. Fratelli M Derivatives of erythropoietin that are tissue protective but not erythro-poietic. Science 2004; 305: 239-42.
32. Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005; 49: 407-17.
33. Li L, Jiang Q, Ding G, Zhang L, Zhang ZG, Li Q, et al. MRI identification of white matter reorganisation enhanced by erythropoietin treatment in a rat model of focal ischemia. Stroke 2009; 40: 936-41.
34. Li Y, Lu Z, Keogh CL, Yu SP, Wei L. Erythropoietin-induced neurovas-cular protection, angiogenesis, and cerebral blood flow restoration after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2007; 27: 1043-54.
35. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 1996; 8: 666-76.
36. Matsuda K, Wang HX, Suo C, McCombe D, Horne MK, Morrison WA, et al. Retrograde axonal tracing using manganese enhanced magnetic resonance imaging. Neuroimage 2010; 50: 366-74.
37. McLeod M, Hong M, Mukhida K, Sadi D, Ulalia R, Mendez I. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur J Neurosci 2006; 24: 361-70.
38. Minnerup J, Heidrich J, Rogalewski A, Schäbitz W-R, Wellmann J. The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke 2009; 40: 3113-20.
39. Musso M, Weiller C, Kiebel S, Mü ller S, Bü lau P, Rijntjes M. Training-induced brain plasticity in aphasia. Brain 1999; 122: 1782-90.
40. Pankratova S, Kiryushko D, Sonn K, Soroka V, Køhler LB, Rathje M, et al. Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor. Brain 2010; 133: 2281-94.
41. Papadopoulos CM, Tsai S-Y, Alsbiei T, O'Brien TE, Schwab ME, Kartje GL. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol 2002; 51: 433-41.
42. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 21: 2019-32.
43. Pluchino S, Muzio L, Imitola J, Deleidi M, Alfaro-Cervello C, Salani G, et al. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 2008; 131: 2564-78.
44. Seymour AB, Andrews EM, Tsai S-Y, Markus TM, Bollnow MR, Brenneman MM, et al. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticor-ubral plasticity in adult rats. J Cereb Blood Flow Metab 2005; 25: 1366-75.
45. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98: 4044-9.
46. Stroemer RP, Kent TA, Hulsebosch CE. Neocortical neuronal sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke 1995; 26: 2135-44.
47. Tan CC, Eckardt KU, Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 1992; 263: F474-81.
48. Taguchi A, Wen Z, Myojin K, Yoshihara T, Nakagomi T, Nakayama D, et al. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur J Neurosci 2007; 26: 126-33.
49. van der Zijden JP, Bouts MJ, Wu O, Roeling TAP, Bleys RL, van der Toorn A, et al. Manganese-enhanced MRI of brain plasticity in relation to functional recovery after experimental stroke. J Cereb Blood Flow Metab 2008; 28: 832-40.
50. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003; 198: 971-5.
51. Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivates. J Cereb Blood Flow Metab 2007; 27: 552-63.
52. Wang L, Zhang Z, Wang Z, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004; 35: 1732-7.
53. Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, et al. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab 2003; 23: 154-65.
54. Zechariah A, ElAli A, Hermann DM. Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix degeneration and DNA fragmentation after focal cerebral ischemia in mice. Stroke 2010; 41: 1008-12.
55. Z'Graggen WJ, Metz GA, Kartje GL, Thallmair M, Schwab ME. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J Neurosci 1998; 18: 4744-57.